Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.45 GBX | 0.00% | -6.45% | +70.59% |
Apr. 26 | Auckett Swanke shares down as half-year loss widens | AN |
Apr. 26 | AIM WINNERS & LOSERS: Proteome Sciences rises on GBP500,000 contract | AN |
Sales 2022 | 7.13M 8.95M | Sales 2023 | 14.1M 17.71M | Capitalization | 5.03M 6.31M |
---|---|---|---|---|---|
Net income 2022 | -2M -2.51M | Net income 2023 | - 0 | EV / Sales 2022 | 0.91 x |
Net Debt 2022 | 2.54M 3.19M | Net Debt 2023 | 4.12M 5.18M | EV / Sales 2023 | 0.65 x |
P/E ratio 2022 |
-1.73
x | P/E ratio 2023 |
44.5
x | Employees | 132 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 26.41% |
1 week | -6.45% | ||
Current month | +16.00% | ||
1 month | +16.00% | ||
3 months | +56.76% | ||
6 months | -3.33% | ||
Current year | +70.59% |
Managers | Title | Age | Since |
---|---|---|---|
Nicholas Clark
CEO | Chief Executive Officer | 49 | 23-04-20 |
Antony Barkwith
DFI | Director of Finance/CFO | 44 | 18-10-31 |
Freddie Jenner
COO | Chief Operating Officer | 40 | 23-06-26 |
Members of the board | Title | Age | Since |
---|---|---|---|
Clive Carver
CHM | Chairman | 63 | 19-05-09 |
Robert Fry
BRD | Director/Board Member | 67 | 18-03-28 |
Tandeep Minhas
BRD | Director/Board Member | 53 | 23-04-23 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 1.45 | 0.00% | 0 |
24-05-02 | 1.45 | 0.00% | 126 |
24-05-01 | 1.45 | 0.00% | 0 |
24-04-30 | 1.45 | +3.57% | 32,831 |
24-04-29 | 1.4 | 0.00% | 121,663 |
Delayed Quote London S.E., May 03, 2024 at 02:59 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+70.59% | 5.31M | |
-12.29% | 3.89B | |
+49.34% | 2.26B | |
+18.64% | 1.95B | |
+26.63% | 1.76B | |
-16.14% | 1.5B | |
+14.84% | 1.16B | |
+14.05% | 1.03B | |
+41.18% | 942M | |
+28.95% | 905M |
- Stock Market
- Equities
- AUK Stock